Gpn1 associates with Gpn3, and both are required for RNA polymerase II nuclear targeting. Global studies have identified by mass spectrometry that human Gpn3 is ubiquitinated on lysines 189 and 216. Our goals here were to determine the type, physiological importance, and regulation of Gpn3 ubiquitination. After inhibiting the proteasome with MG132, Gpn3-Flag was polyubiquitinated on K216, but not K189, in HEK293T cells. Gpn3-Flag exhibited nucleocytoplasmic shuttling, but polyubiquitination and proteasomal degradation of Gpn3-Flag occurred only in the cell nucleus. Polyubiquitination-deficient Gpn3-Flag K216R displayed a longer half-life than Gpn3-Flag in two cell lines. Interestingly, Gpn1-EYFP inhibited Gpn3-Flag polyubiquitination in a dose-dependent manner. In conclusion, Gpn1-inhibitable, nuclear polyubiquitination on lysine 216 regulates the half-life of Gpn3 by tagging it for proteasomal degradation.
The Gpn family is formed by the essential and highly conserved proteins Gpn1, Gpn2, and Gpn3 and owes its name to an invariable glycine-proline-asparagine (GPN) motif [1] . Although very little is known about these proteins, all three have been shown to co-purify with RNA polymerase II (RNAPII) [2] [3] [4] [5] [6] . In mammalian cells, both Gpn1 and Gpn3 are required for the nuclear localization of RNAPII [4, 6] . The similarity in the phenotype observed after suppressing Gpn1 or Gpn3 suggests that these two GTPases function in the same pathway. Gpn1 and Gpn3 strongly interact in human cells, and the stability of each protein depends on the presence of the other [7] . Global analyses employing mass spectrometry reported that Gpn3 is ubiquitinated on lysines 189 [8] and 216 [9, 10] . Gpn3 interacts with some components of the ubiquitination machinery such as the E3 ligase cullin 5 [11] and WDR48 [12] , a deubiquitination complex regulator.
Ubiquitination is a post-translational modification that plays an important role in controlling cell cycle, signal transduction, degradation, apoptosis, and many other cellular processes [13] [14] [15] [16] . Ubiquitination is a multi-enzymatic process in which the ubiquitin protein is attached to a substrate protein through a lysine in a process involving three essential steps. Initially, ubiquitin is activated in its C-terminal glycine by ATP and the E1 ubiquitin-activating enzyme. Following activation, an E2 ubiquitin-conjugating enzyme transfers ubiquitin from E1 to the substrate via an E3 ubiquitin-ligase. Ubiquitin is transferred to an e-amino group of a Lys residue on the protein substrate to generate an isopeptide bond [17, 18] .
Protein substrates are specifically recognized by different E3s [19] . Some types of polyubiquitination induce protein degradation by the 26S-proteasome [20] . In other cases, ubiquitination takes part in the functional regulation of a substrate protein [21, 22] .
In this study, we directly determined if Gpn3 is indeed ubiquitinated and the physiological relevance of this modification. We showed that Gpn3 is polyubiquitinated in the presence of MG132. Most of this ubiquitin chains initiate at lysine 216, as they were drastically reduced in the Gpn3-Flag K216R mutant. Interestingly, Gpn3 was polyubiquitinated in the cell nucleus, where it accumulated in the presence of MG132. Finally, we demonstrated that the co-transfection of Gpn1 decreased Gpn3 ubiquitin conjugates in a concentration-dependent manner. These results indicate that polyubiquitination on lysine 216 is a regulatory process for proteasomal degradation of Gpn3 that is not in a complex with Gpn1, a critical partner of Gpn3 in mammalian cells [7] .
Materials and methods

Antibodies and reagents
Anti-mouse and anti-rabbit immunoglobulins G conjugated to horseradish peroxidase and mouse monoclonal antitubulin antibodies were obtained from Sigma (St. Louis, MO, USA). Mouse monoclonal Rpb1 antibody (8WG16) was from Covance (Emerville, CA, USA). Chemical reagents were obtained from Sigma, and all tissue culture reagents were from Invitrogen (Carlsbad, CA, USA).
Generation of molecular constructs for Gpn3R-Flag and mutants
Full-length cDNA for human Gpn3R-Flag was inserted into the Bglll and HindIII sites of the pEYFP-N1 vector introducing a stop codon after Flag to prevent EYFP tag expression. The Flag tag was included in the 3 0 primer. cDNA for human Gpn1 was obtained as described previously [23] . Gpn3 mutants (K189R, K210R, K216R, and K210R/ K216R) were generated by site-directed PCR mutagenesis using Gpn3R-Flag as template. The coding regions in all final constructs were fully sequenced to verify that they contained only the intended mutation.
Stable expression of wild-type and Gpn3R-Flag mutants
Gpn3R-Flag and indicated mutants were subcloned into the NotI and HindIII sites of the pLNCX2 retroviral vector. Viral particles were generated and used as described [6] . HEK-AD-293 were selected by adding 0.75 mgÁmL
À1
geneticin to the culture media.
shRNAs-mediated depletion of Gpn3
To stably suppress expression of endogenous Gpn3, we employed a retroviral vector to express the short-hairpin RNA g193, as described [6] . HEK-AD-293 were selected by adding 2.5 lgÁmL À1 puromycin to the culture media. 
Cell culture conditions
Cell fractionation of MCF-12A cells
We selectively permeabilized the plasma membrane with digitonin and collected the soluble and insoluble fractions, as described [24] . The nuclear fraction remains associated with the insoluble fraction, whereas cytosolic proteins are recovered in the supernatant.
Western blot analyses
Samples were separated on SDS/PAGE gels [25] , and then electrophoretically transferred in a semi-dry system to polyvinylidene membranes. Western blot assays were performed as previously described [6] .
Results
Gpn3R-Flag is polyubiquitinated in transiently transfected HEK293T cells
We first determined the appropriate experimental conditions to study Gpn3 ubiquitination in vivo. We transiently transfected HEK293T cells with Ha-ubiquitin and Gpn3R-Flag. The 'R' in Gpn3R-Flag stands for 'resistant' to the shRNA g193, which will be used later in some experiments to suppress the expression of endogenous Gpn3. Twenty-four hour later, the proteasome inhibitor MG132 was added to the culture medium and Gpn3R-Flag was immunoprecipitated from the soluble fraction with an anti-Flag antibody. Cell extracts and Flag immunoprecipitates were analyzed by western blot with a Gpn3-specific antibody. MG132 treatment caused a marked increase in unmodified Gpn3R-Flag protein levels (Fig. 1A , input lanes).
In addition, a series of slow-migrating species of Gpn3R-Flag were also detected in the Flag immunoprecipitates by the Gpn3 antibody (Fig. 1A) . These slow-migrating species of Gpn3R-Flag were also recognized by an anti-Ha antibody employed to visualize Ha-ubiquitin (Fig. 1B) , a result consistent with Gpn3R-Flag being polyubiquitinated. Importantly, the Ha-ubiquitin signal was still detected when the Gpn3R-Flag immunoprecipitation was performed with the stronger RIPA buffer instead of the usual triton X-100 containing buffer (Fig. 1C) , indicating that the Ha-ubiquitin originates from Ha-ubiquitin covalently attached to Gpn3R-Flag, and not from Gpn3-associated proteins. As these ubiquitin conjugates were observed only after inhibiting the proteasome with MG132, these results indicate that Gpn3R-Flag is tagged by polyubiquitination for degradation in the 26S proteasome [26] .
In vivo polyubiquitination of Gpn3R-Flag occurs mainly on lysine 216
Since ubiquitin is attached to proteins via lysine residues [17, 18] , we use site-directed mutagenesis to substitute lysines potentially acting as ubiquitin acceptors. Global analyses employing mass spectrometry have The incorporation of Ha-ubiquitin into slow-mobility species of Gpn3R-Flag observed in the presence of the proteasome inhibitor MG132 was significantly decreased in Gpn3R-Flag K216R but not in Gpn3R-Flag K189R. The same samples in A were probed with an anti-Ha antibody to visualize Ha-ubiquitin. (C) Remaining polyubiquitination in Gpn3R-Flag K216R is abolished in the Gpn3R-Flag K216R/K210R double mutant. HEK293T cells were transiently transfected with Ha-ubiquitin and Gpn3R-Flag, Gpn3R-Flag K210R, Gpn3R-Flag K216R or Gpn3R-Flag K210R/K216R, as indicated. Twenty-four hour later the cells were treated with 10 lM MG132 for 3 h, followed by Gpn3R-Flag immunoprecipitation with a Flag antibody. Flag immunoprecipitates were probed with an anti-Gpn3 antibody. (D) The incorporation of Ha-ubiquitin into slow-mobility species of Gpn3R-Flag observed in the presence of the proteasome inhibitor MG132 are further decreased in the Gpn3R-Flag K216R/K210R double mutant. The same samples in C were probed with an anti-Ha antibody to visualize Ha-ubiquitin. (E) The HEK293T cells transfection efficiency for Ha-ubiquitin was similar in Gpn3R-Flag-or Gpn3R-Flag K216R-transfected cells. Transfected cells were identified by its ability to express Ha-ubiquitin, which we visualized in immunofluorescence experiments with an anti-Ha antibody. In every case, the result of a representative experiment is shown, but each experiment was repeated at least four times.
shown that Gpn3 is ubiquitinated on lysines 189 [8] and 216 [9, 10] . We next determined the importance of lysines 189 and 216 in the ubiquitination of Gpn3R-Flag in transiently transfected HEK293T cells. We mutated K189 and K216 to arginine to conserve the net positive charge of lysine [27] . Ubiquitination of Gpn3R-Flag K189R was not significantly different from that of Gpn3R-Flag ( Fig. 2A) . In contrast, conjugation of Ha-ubiquitin to Gpn3R-Flag K216R was markedly attenuated when visualizing the slow-migrating species with either a Gpn3 antibody ( Fig. 2A) or an Ha antibody to detect Ha-ubiquitin (Fig. 2B ).
These results indicate that under our experimental conditions, ubiquitination of Gpn3 occurs mainly on lysine 216. As ubiquitination of Gpn3 was not entirely inhibited in Gpn3R-Flag K216R, we investigated the importance of other lysines in Gpn3R-Flag ubiquitination. Among several individual lysine-to-arginine Gpn3 mutants examined, only Gpn3R-Flag K210R was slightly less ubiquitinated than Gpn3R-Flag ( Fig. 2C and results not shown). Next, we introduced the K210R mutation into Gpn3R-Flag K216R to generate the Gpn3R-Flag K210R/K216R double mutant.
Ubiquitination of Gpn3R-Flag K210R/K216R was further decreased compared to Gpn3R-Flag K216R when the slow-migrating Gpn3R-Flag species were visualized by detecting directly Gpn3 (Fig. 2C) or Haubiquitin with an anti-Ha antibody (Fig. 2D) . Importantly, the transfection efficiency of the HEK293T cells expressing Gpn3R-Flag or Gpn3R-Flag K216R was very similar (Fig. 2E) . Our results convincingly show that polyubiquitination of Gpn3 occurs through lysines 210 and 216, although mainly through lysine 216. These findings indicate that in our experimental conditions, polyubiquitination of Gpn3 occurs on lysine 216, the same residue as the ubiquitination described for endogenous Gpn3 in untreated cells [9, 10] .
Protein levels of Gpn3R-Flag, but not the polyubiquitination-defective Gpn3R-Flag K216R, increase in the cell nucleus in the presence of MG132
We next investigated the subcellular compartment where Gpn3R-Flag is ubiquitinated. For this purpose, we first generated retroviral molecular constructs to stably express Gpn3R-Flag or Gpn3R-Flag K216R in MCF-12A cells, as previously described [7] . Western blot analysis showed that Gpn3R-Flag and Gpn3R-Flag K216R were stably expressed in MCF-12A cells at similar levels (Fig. 3A) . Exposure of MCF-12A cells stably expressing Gpn3R-Flag to the proteasome inhibitor MG132 increased Gpn3R-Flag protein levels in a time-dependent manner (Fig. 3B) . It is known that sometimes ubiquitination may alter the subcellular distribution of a target protein [28, 29] . Next, we investigated if the increase in Gpn3R-Flag protein levels occurred in a specific subcellular compartment by immunofluorescence in MCF-12A cells. In untreated MCF-12A cells, Gpn3R-Flag and Gpn3R-Flag K216R displayed a weak signal restricted to the cytoplasm (Fig. 3C) . Wild-type Gpn3R-Flag (Fig. 3C , second row) but not Gpn3R-Flag K216R (Fig. 3C , fourth row) signal strongly increased in the cell nucleus of MCF-12A cells exposed to MG132. Quantitative analysis of these data was performed using the program IMAGEJ (NIH, Bethesda, MD, USA) (Fig. 3D) . We next tested if the immunofluorescence signal correlated with an increase in nuclear Gpn3R-Flag protein levels visualized by western blot. A large increase in Gpn3R-Flag but not Gpn3R-Flag K216R protein levels was detected in the insoluble fraction of digitonin-permeabilized MCF-12A cells exposed to MG132 (Fig. 3E) , the fraction that contains the cell nuclei, as corroborated by the presence of Rpb1, the largest subunit of RNA polymerase II. Thus, exposure of MCF-12A cells to MG132 increased Gpn3R-Flag but not Gpn3R-Flag K216R protein levels specifically in the cell nucleus.
Gpn3R-Flag is polyubiquitinated in the cell nucleus
We then asked if polyubiquitination of Gpn3R-Flag occurs in the cytoplasm and subsequently this modified Gpn3R-Flag was transported into the cell nucleus or, alternatively, if Gpn3R-Flag was first imported into the cell nucleus and subsequently polyubiquitinated and degraded by nuclear proteasomes. We started by investigating if there was a movement of Gpn3R-Flag between the cytoplasm and the nucleus in untreated cells. MCF-12A cells stably expressing Gpn3R-Flag or Gpn3R-Flag K216R were exposed to leptomycin B (LMB), a chemical inhibitor of the nuclear export factor Crm1, and evaluated the subcellular distribution of Gpn3R-Flag and Gpn3R-Flag K216R by immunofluorescence. Both Gpn3R-Flag and Gpn3R-Flag K216R accumulated in the cell nucleus of MCF-12A cells with equal efficiency in the presence of LMB (Fig. 4A) . These results indicate that both Gpn3R-Flag and Gpn3R-Flag K216R are transported with equal efficiency in and out of the cell nucleus in MCF-12A cells under basal conditions. Then, we asked if we could prevent the increase in Gpn3R-Flag nuclear accumulation observed after inhibiting the proteasome with MG132 by preventing Gpn3R-Flag nuclear entry with ivermectin, an inhibitor of importin a/b mediated nuclear import [30] . The nuclear increase in Gpn3R-Flag protein levels observed after inhibiting the proteasome with MG132 was completely prevented by ivermectin (Fig. 4B) . Importantly, when we first trap Gpn3R-Flag in the nucleus of MCF-12A cells with LMB, and then expose those cells to MG132, the slow-migrating species of Gpn3R-Flag were still detected in cell extracts with an anti-Gpn3 antibody (Fig. 4C) . However, the slowmigrating species of Gpn3R-Flag were not visible when we blocked Gpn3R-Flag nuclear import with ivermectin before exposing MCF-12A cells to MG132 (Fig. 4C) . Altogether, these results indicate that Gpn3R-Flag is first imported into the cell nucleus and then polyubiquitinated. Most likely, polyubiquitinated Gpn3R-Flag will subsequently be degraded by nuclear proteasomes.
The polyubiquitination-defective Gpn3R-Flag K216R mutant has a prolonged half-life compared to Gpn3R-Flag Next, we investigated if ubiquitination of Gpn3 on lysine 216 played any role in regulating its half-life. MCF-12A cells stably expressing either wild-type Gpn3R-Flag or Gpn3R-Flag K216R were infected with a retrovirus expressing the shRNA g193, which is highly effective to suppress the expression of endogenous Gpn3 [6] , or with the ineffective shRNA g239 used as control. Western blot assays of total cell extracts from cells surviving in the presence of puromycin showed that endogenous Gpn3 was effectively suppressed by the shRNA g193 in MCF-12A cells expressing Gpn3R-Flag or Gpn3R-Flag K216R (Fig. 5A) . We next treated Gpn3R-Flag or Gpn3R-Flag K216R MCF-12A expressing cells with 30 lgÁmL À1 cycloheximide (CHx) to inhibit new protein synthesis, and total cell extracts were prepared at different time points to determine by western blot the fraction of Gpn3R-Flag and Gpn3R-Flag K216R remaining in the cells [31] . As new protein synthesis is inhibited by CHx, Gpn3R-Flag and Gpn3R-Flag K216R protein levels at different time points should closely correlate with their degradation rate. Gpn3R-Flag progressively decreased and was detected until 4 h of CHx exposure (Fig. 5B) . In contrast, Gpn3R-Flag K216R protein levels decreased more slowly, and the Gpn3R-Flag K216R protein was still detected even after 12 h of CHx exposure (Fig. 5B) . These results were quantified with the software IM-AGEJ (Fig. 5C ). We next tested if Gpn3 half-life was also controlled by ubiquitination on lysine 216 in a different cell type. HEK-AD 293 cells stably expressing Gpn3R-Flag or Gpn3R-Flag K216R were generated with retroviral vectors. HEK-AD 293 cell derivatives expressing similar protein levels of Gpn3R-Flag or Gpn3R-Flag K216R were subsequently infected with retrovirus expressing either the shRNA g193 to suppress the expression of endogenous Gpn3, or the ineffective shRNA g239 as a control. Endogenous Gpn3 protein levels were effectively decreased in HEK-AD 293 cells expressing Gpn3R-Flag or Gpn3R-Flag K216R (Fig. 5D) . We then proceed to examine the half-life of Gpn3R-Flag and Gpn3R-Flag K216R in the absence of endogenous Gpn3. Whereas Gpn3R-Flag was barely detected after 6 h of CHx treatment, Gpn3R-Flag K216R was still detected in cells after 10 h of CHx exposure (Fig. 5E ). Results were again quantified using the software IMAGEJ (Fig. 5F) . Altogether, the results obtained in two different cell types, MCF-12A and HEK-AD 293 cells, showed that the half-life of Gpn3 increased in the ubiquitination-defective Gpn3R-Flag K216R mutant. Thus, proteasomal degradation induced by polyubiquitination of Gpn3 on lysine 216 plays a critical role in determining the half-life of Gpn3. Ivermectin inhibits the increase in Gpn3R-Flag protein levels in the nucleus observed after exposing MCF-12A cells to MG132. MCF-12A cells stably expressing Gpn3R-Flag were preincubated for 1 h with ivermectin and then exposed again to ivermectin plus MG132. Gpn3R-Flag was visualized by immunofluorescence with an anti-Flag antibody. (C) Gpn3R-Flag is polyubiquitinated in the cell nucleus of MCF-12A cells. MCF-12A cells stably expressing Gpn3R-Flag were pre-incubated with either ivermectin or LMB to restrict Gpn3-Flag to the cytoplasm or cell nucleus, respectively, followed by a 4-h exposure to the same drug plus MG132. Total cell extracts were probed with an anti-Gpn3 antibody.
Polyubiquitination of Gpn3R-Flag is prevented by Gpn1-EYFP in vivo
We previously reported that Gpn3 strongly interacts with Gpn1 to form a single protein complex in mammalian cells [7] . Additionally, suppression of Gpn1 expression led to a significant decrease in Gpn3 protein levels, demonstrating that Gpn3 stability does critically depend on the presence of Gpn1. With this background, we asked if Gpn1 might regulate Gpn3 polyubiquitination. To answer this question, we transiently transfected HEK293T cells with The polyubiquitination-defective Gpn3R-Flag K216 mutant has an increased half-life compared with wild-type Gpn3R-Flag in MCF-12A cells. MCF-12A cells stably expressing only Gpn3R-Flag or Gpn3R-Flag K216R were exposed to 30 lM cycloheximide (CHx) to block new protein synthesis. At the indicated times, the protein levels of Gpn3 remaining were detected in total cell extracts by western blot with an anti-Gpn3 rabbit polyclonal antibody. (C) Quantification of the results in (B). Results are means AE SD of three independent experiments. The IMAGEJ software was employed to quantify the percentage of Gpn3R-Flag or Gpn3R-Flag K216R remaining at each time point. (D) Molecular replacement of endogenous Gpn3 by Gpn3R-Flag or Gpn3R-Flag K216R in HEK-AD 293 cells. HEK-AD 293 cells stably expressing either Gpn3R-Flag or Gpn3R-Flag K216R were infected with retroviral particles expressing the shRNA control g239 or the shRNA g193 to suppress endogenous Gpn3 expression. Endogenous Gpn3, Gpn3R-Flag, and Gpn3R-Flag K216R were visualized with an anti-Gpn3 rabbit polyclonal antibody (upper panels). Gpn3R-Flag and Gpn3R-Flag were also detected with an anti-Flag antibody (middle panel). Tubulin was measured as a loading control (lower panel). (E) The polyubiquitination-defective Gpn3R-Flag K216 mutant has an increased half-life compared with wild-type Gpn3R-Flag in HEK-AD 293 cells. HEK-AD 293 cells stably expressing Gpn3R-Flag or Gpn3R-Flag K216R in the absence of endogenous Gpn3 were exposed to 30 lM cycloheximide (CHx) to block new protein synthesis. At the indicated times, the remaining Gpn3R-Flag and Gpn3R-Flag K216R were detected in total cell extracts by western blot with an anti-Gpn3 rabbit polyclonal antibody (upper panels). Tubulin was employed as a loading control (lower panels). (F) Quantification of the results shown in (E). Results are means AE SD of three independent experiments. The IMAGEJ software was employed to quantify the percentage of Gpn3R-Flag or Gpn3R-Flag K216R remaining at each time point after CHx addition.
Ha-ubiquitin, Gpn3R-Flag, and increasing amounts of Gpn1-EYFP. Twenty-four hours later, MG132 was added to the culture medium for 3 h and Gpn3R-Flag was immunoprecipitated from the soluble fraction with an anti-Flag antibody. Cell extracts and Flag immunoprecipitates were analyzed by western blot with either a Gpn3 (Fig. 6A) or Haubiquitin (Fig. 6B) antibody. In the absence of Gpn1-EYFP, polyubiquitination of Gpn3 was very prominent, as expected from the results previously described (lane 5, IP Flag in Fig. 6A,B) . However, as the amount of Gpn1-EYFP expressing plasmid increased in the transfection mix, the ubiquitin conjugates of Gpn3R-Flag progressively decreased (compare lanes 5-8, IP Flag, in Fig. 6A,B) . As expected, Gpn1-EYFP protein levels increased together with the amount of plasmid (Fig. 6A, lower panel) . The transfection efficiency in all these conditions was very similar, as evaluated by the percentage of cells expressing Ha-ubiquitin (Fig. 6C) . Based on these results, we propose that polyubiquitination of Gpn3 is a process tightly controlled by Gpn1, an important partner of Gpn3 in mammalian cells.
Discussion
The development of an antibody that specifically recognizes a di-glycine motif attached to the e-amine of lysine allowed the identification by mass spectrometry of Gpn3, among many other proteins being ubiquitinated in HEK293 cells under basal conditions [9] . Gpn3 was reported ubiquitinated on lysine 216, a finding confirmed in a second global study by Mertins et al. [10] . These global studies are extremely helpful not only because they generate large lists of ubiquitinated proteins, but also because they identify the precise residue in the protein where the modification occurs. However, it is necessary to first confirm these results for individual proteins and then determine if this ubiquitination corresponds to mono, multi or polyubiquitination, as well as physiological relevance and regulation. Here, we demonstrated that in transiently transfected HEK293T cells, ubiquitinated Gpn3 accumulates in the presence of the proteasome inhibitor MG132. These ubiquitin conjugates corresponded to polyubiquitination, and the main ubiquitin acceptor on Gpn3 was lysine 216. Polyubiquitination on lysine 216 tagged Gpn3 for proteasome degradation, as inhibition of the proteasome with MG132 significantly increased the protein levels of nonmodified Gpn3 and caused the appearance of slow-migrating polyubiquitinated species of Gpn3. To evaluate the physiological importance of Gpn3 ubiquitination on lysine 216, we employed two retroviral vectors and interference RNA to generate two different cell lines that stably express wild-type Gpn3R-Flag or the polyubiquitination-deficient Gpn3R-Flag K216R in the absence of endogenous Gpn3. In both cell lines, the half-life of the Gpn3R-Flag K216R mutant was clearly prolonged compared with Gpn3R-Flag. Finally, we demonstrated that polyubiquitination of Gpn3 occurred in the cell nucleus and that it was prominent when expressing Gpn3 alone, but that this process was inhibited in a dose-dependent manner by co-transfecting Gpn1, a critical Gpn3 partner in human cells [7] .
The fact that in our experiments polyubiquitination of Gpn3R-Flag was markedly inhibited in the Gpn3R-Flag K216R mutant was reassuring to us, as this indicates that transiently transfecting HEK293T cells to study Gpn3 ubiquitination is a valid system to determine its properties and physiological relevance, as ubiquitination occurs mainly on lysine 216, the same residue ubiquitinated in endogenous Gpn3 in unperturbed cells [9, 10] . Although the identity of the molecular machinery involved in the polyubiquitination of Gpn3 on lysine 216 remains unknown, it is worth noting its remarkable specificity. Although lysine 216 is part of a 'lysine patch' in Gpn3 that includes K209, K210, K213, K214, and K216, polyubiquitination of Gpn3-Flag was significantly prevented in the Gpn3R-Flag K216R mutant. Low levels of ubiquitin conjugates seem to also occur on lysine K210, as the residual polyubiquitination observed in Gpn3R-Flag K216R disappeared in the Gpn3R-Flag K216R/K210R double mutant. Although another global study [8] documented the ubiquitination of Gpn3 on lysine 189, this site was not involved in the ubiquitination of Gpn3 under our experimental conditions. Ubiquitination of Gpn3 on lysine 216 may be a critical factor to determine the half-life of Gpn3, as the half-life of the polyubiquitination-defective Gpn3R-Flag K216R mutant was clearly extended over that of the wild-type Gpn3R-Flag protein in two different cell types, MCF-12A (Fig. 5B,C) and HEK-AD 293 (Fig. 5D ,E) cells stably expressing these proteins in the absence of endogenous Gpn3. Thus, we conclude that polyubiquitination of Gpn3 on lysine 216 is an effective mechanism to tag this protein for degradation by the 26S proteasome. As Gpn3R-Flag protein levels increase in the cell nucleus in the presence of MG132, and Gpn3R-Flag was polyubiquitinated even when MG132 was added to cells retaining most Gpn3R-Flag in the cell nucleus due to LMB exposure, it is very likely that Gpn3 polyubiquitination and degradation occur in the cell nucleus.
Polyubiquitination of Gpn3 on lysine 216 was highly effective when Gpn3 was expressed alone, but this modification was inhibited by co-expressing Gpn1-EYFP in a dose-dependent manner. This may indicate that Gpn3 is not folded properly in the absence of Gpn1, a hypothesis consistent with our previous observation that Gpn1 and Gpn3 form a tight single complex in mammalian cells, and that suppression of Gpn1 with a specific shRNA dramatically decreases Gpn3 protein levels [7] . However, other explanations are clearly possible. One scenario could be that lysine 216 or a degron sequence may be accessible to the ubiquitination machinery only when Gpn3 is alone but not when bound to Gpn1. However, our molecular modeling experiments do not place lysine 216 at the Gpn3-Gpn1 interface (results not shown). Another possibility is that Gpn1 inhibits Gpn3 ubiquitination by preventing Gpn3 from reaching the nucleus, the cell compartment where Gpn3 ubiquitination seems to occur. In transiently transfected HEK293T cells, Gpn3-EYFP expressed alone reaches the cell nucleus but is effectively retained in the cytoplasm when co-transfected with Gpn1 [7] . Our results showing that wild-type but not K216R Gpn3R-Flag accumulates in the nucleus of cells exposed to MG132, and that nuclear Gpn3R-Flag trapped by LMB is polyubiquitinated, support the proposal that Gpn3 is ubiquitinated and degraded by the proteasome in the cell nucleus. Regardless of the specific molecular mechanism, polyubiquitination of Gpn3 is a process tightly controlled by Gpn1. Thus, nuclear polyubiquitination of Gpn3 on lysine 216 seems to be a very effective posttranslational mechanism employed by mammalian cells to eliminate Gpn3 that is in excess of Gpn1, Gpn3 that has been damaged, or Gpn3 that has abnormally separated from Gpn1.
